Test Code TCGBM T-Cell Receptor Gene Rearrangement, PCR, Bone Marrow
Reporting Name
T Cell Receptor Gene Rearrange, BMUseful For
Determining whether a T-cell population is polyclonal or monoclonal
Testing Algorithm
For information see:
-Bone Marrow Staging for Known or Suspected Malignant Lymphoma Algorithm
Method Name
Polymerase Chain Reaction (PCR)
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
Bone MarrowShipping Instructions
Specimen must arrive within 7 days of collection.
Necessary Information
Include relevant clinical information and cytogenetics results, if available.
Specimen Required
Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Yellow top (ACD)
Specimen Volume: 2 mL
Collection Instructions:
1. Invert several times to mix bone marrow.
2. Send bone marrow specimen in original tube. Do not aliquot.
Specimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Bone Marrow | Ambient (preferred) | 7 days | |
Refrigerated | 7 days |
Reject Due To
Gross hemolysis | Reject |
Moderately to severely clotted | Reject |
Special Instructions
Reference Values
An interpretive report will be provided.
Positive, negative, or indeterminate for a clonal T-cell population
Day(s) Performed
Monday through Friday
CPT Code Information
81340-TCB (T cell antigen receptor, beta) (eg, leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using amplification methodology (eg, PCR)
81342-TCG (T cell receptor, gamma) (eg, leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
TCGBM | T Cell Receptor Gene Rearrange, BM | In Process |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
19957 | Final Diagnosis: | 22637-3 |
608952 | Signing Pathologist | 19139-5 |
Test Classification
This test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.Report Available
5 to 10 daysNY State Approved
YesForms
1. Hematopathology Patient Information (T676)
2. If not ordering electronically, complete, print, and send a Hematopathology/Cytogenetics Test Request (T726) with the specimen.